Women’s health startup Maven Clinic closes $125 million in funding at a $1.7 billion valuation

It’s been four years since we last covered Maven Clinic, a female-led startup focused on virtual care for women and families.  The startup gained attention after raising $45 million in Series C funding to transform women’s healthcare.

Fast forward to today, and Maven has just secured a $125 million funding round, pushing its valuation to $1.7 billion. High-profile investors, including General Catalyst, Sequoia, Oak HC/FT, and celebrities like Oprah Winfrey, Mindy Kaling, and Reese Witherspoon, participated in the round.

What stands out about this milestone is that Maven has become the first U.S. startup dedicated to women’s and family health to achieve unicorn status—a valuation exceeding $1 billion.

Founded in 2014 by Katherine Ryder, Maven offers a digital care clinic designed to support mothers and families through every stage of family planning, pregnancy, postpartum, and beyond. Its services include video consultations and private messaging with healthcare professionals, along with a family benefits platform. Maven’s offerings cover everything from IVF and egg-freezing to pregnancy, adoption, surrogacy, and career coaching. The company serves individuals, employers, and healthcare providers alike.

Maven aims to provide care across the entire reproductive life cycle, addressing the needs of those planning a family, during pregnancy, postpartum, and even through menopause.

In an interview with CNBC, Ryder shared that she founded the company after seeing her friends struggle to find the support they needed while starting their families. Today, Maven covers around 17 million people through partnerships with health plans and employers, including major companies like Amazon, Microsoft, and AT&T.

“Digital health is just getting started,” Ryder told CNBC. While the company is focused on expanding its product offerings, it has its sights set on eventually going public. Maven has earned a spot on the CNBC Disruptor 50 list for three consecutive years, CNBC reported.

Maven (Credit: Maven Clinic)

Women’s health, especially reproductive health, is a key issue in the upcoming presidential race between Vice President Kamala Harris and former President Donald Trump. Ryder mentioned that Maven is willing to share its data and insights on policy, regardless of the election outcome.

Maven gained attention after the Supreme Court decided to overturn Roe v. Wade in 2022. In response, the company stepped up to help employers navigate new challenges in healthcare access. Ryder called the ruling a “devastating setback” for U.S. healthcare in a blog post, highlighting how Maven’s clients could use the platform to help patients with travel reimbursements for out-of-state care. Interest in travel benefits and pregnancy-related care surged 67% month-over-month following the ruling.

That same year, venture funding in women’s health startups saw a modest 5% increase, according to Deloitte, while overall health tech investments fell by 27%. Maven raised $90 million in November of that year, bucking the broader downward trend in the market.

As more data becomes available about women’s health, companies like Maven are helping paint a clearer picture of the ongoing challenges, especially in a post-Roe landscape. Ryder noted that while funding and research are on the rise, the data often reveals grim realities, including preventable deaths due to restricted access to care.

“I think between more funding and research, more data points from states, from platforms like ourselves, you can start to point and paint a complete picture of everything going on that helps change policy for the better,” Ryder said. “The question is, to be honest, when? And how many more people need to needlessly suffer in the meantime?”